FSD Pharma Inc.(CSE: HUGE,
OTCQB: FSDDF,
Forum) stated on Tuesday that it has received a license to sell to other licensed producers through its wholly-owned subsidiary,
FV Pharma Inc. under the Access to Cannabis for Medical Purposes Regulations. The Company is also expanding its growth production footprint.
For more on this, click
here.
FSD was in the news recentlywhen it announced that that its partner,
SciCann Therapeutics Inc., received a positive International Search Authority report from the Patent Cooperation Treaty for its SCN-001 cannabidiol combination therapy patent, the basis of FSD’s “Steady Stomach” product.
FULL DISCLOSURE: FSD Pharma Inc. is a paid client of Stockhouse Publishing.